You can buy or sell Omeros and other stocks, options, and ETFs commission-free!
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. Read More It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. The listed name for OMER is Omeros Corporation Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 9, After Hours